Patents by Inventor Bernard I. Weinstein

Bernard I. Weinstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis Of Primary Open Angle Glaucoma
    Publication number: 20080058429
    Abstract: The invention provides methods for diagnosing patients with primary open angle glaucoma (POAG), as well as methods for identifying agents for use in treating POAG and methods of using such agents in prevention and treatment of the disease.
    Type: Application
    Filed: February 13, 2004
    Publication date: March 6, 2008
    Inventors: A Louis Southren, Bernard I. Weinstein, Victor A. Fried
  • Degrading sludge with microorganisms ATCC 55926 OR 202050
    Patent number: 6420165
    Abstract: A biologically pure culture of a microorganism is provided designated SH2A and deposited under ATCC Accession No. 55926, or a mutant derived therefrom. Further provided is a biologically pure culture of a microorganism designated SH2B and deposited under ATCC Accession No. 202050, or a mutant derived therefrom. A method of degrading an organic material such as sludge is carried out by treating the organic material with an effective, degrading amount of either SH2A or a mutant derived therefrom, or SH2B or a mutant derived therefrom. The microorganism designated SH2A or a mutant derived therefrom, or SH2B or a mutant derived therefrom, is grown by culturing the microorganism at a temperature and in a medium effective to promote growth of the microorganism.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: July 16, 2002
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Bernard I. Weinstein, David Figurski, Sadayori Hoshina, Koji Nakanishi
  • Use of decreased 3-alpha-hydroxysteroid dehydrogenase activity in peripheral lymphocytes or other cells of patients with primary open angle glaucoma as a diagnostic indicator
    Patent number: 5376534
    Abstract: An assay for determining patients either having Primary Open Angle Glaucoma or at risk of developing Primary Open Angle Glaucoma. The assay involves testing cells, preferably lymphocyte cells, for 3.alpha.-HSD activity and determining from the level of assayed activity whether the patient is either suffering from Primary Open Angle Glaucoma or at risk therefor.
    Type: Grant
    Filed: December 17, 1993
    Date of Patent: December 27, 1994
    Assignee: New York Medical College
    Inventors: A. Louis Southren, Bernard I. Weinstein, Gary G. Gordon
  • Tetrahydrocortisol in glaucoma therapy
    Patent number: 4997826
    Abstract: Pharmaceutical compositions comprising tetrahydrocortisol and method of using same in the control of intraocular pressure are disclosed.
    Type: Grant
    Filed: August 21, 1989
    Date of Patent: March 5, 1991
    Assignee: New York Medical College
    Inventors: Aaron L. Southren, Bernard I. Weinstein, Gary G. Gordon
  • Use of tetrahydrocortisol in glaucoma therapy
    Patent number: 4863912
    Abstract: Pharmaceutical compositions comprising tetrahydrocortisol and method of using same in the control of intraocular pressure are disclosed.
    Type: Grant
    Filed: May 19, 1986
    Date of Patent: September 5, 1989
    Assignee: New York Medical College
    Inventors: Aaron L. Southren, Bernard I. Weinstein, Gary G. Gordon